Genomic Biomarkers

Genomic biomarkers are measurable genetic indicators that help reveal an individual’s risk of disease, response to treatment, or likelihood of experiencing adverse drug reactions. These biomarkers include gene mutations, copy number variations, expression profiles, and epigenetic signatures that provide valuable insights into underlying biological mechanisms. By identifying specific genomic patterns, clinicians can diagnose diseases earlier, classify subtypes more accurately, and tailor therapies to match a patient’s molecular profile. Genomic biomarkers have become essential tools in oncology, cardiovascular medicine, neurology, and metabolic disorders, enabling precise prediction of therapeutic outcomes. Their role extends to monitoring disease progression, evaluating treatment effectiveness, and guiding personalized prevention strategies.

×

Contact Emails

genomics@confmeets.net
support@confmeets.com
finance@confmeets.com

Article Processing Timeline

2-5 Days Initial Quality & Plagiarism Check
15
Days
Peer Review Feedback
85% Acceptance Rate (after peer review)
30-45 Days Total article processing time

Indexed In

Google Scholar
ResearchBib
Sindexs
OAJI
DOAJ
CrossRef
PubMed
MEDLINE
EBSCO A-Z / Host
OCLC - WorldCat

Journal Flyer

Flyer Image